CARsgen Therapeutics Holdings Ltd CRTHF:OTCPK

*Data is delayed | Exchange | USD
Last | 12/04/23 EDT
1.67UNCH (UNCH)
52 week range
1.67 - 1.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.67
  • 52 Week High1.67
  • 52 Week High Date12/04/23
  • 52 Week Low1.67
  • 52 Week Low Date12/04/23

Key Stats

  • Market Cap441.44M
  • Shares Out575.64M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.67
  • 52 Week High1.67
  • 52 Week High Date12/04/23
  • 52 Week Low1.67
  • 52 Week Low Date12/04/23
  • Market Cap441.44M
  • Shares Out575.64M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.19
  • P/E (TTM)-8.81
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CARsgen Therapeutics Holdings Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally engaged in discovering, developing and commercializing innovative chimeric antigen receptor (CAR)-T cell therapies. The Company’s therapies are applied in the treatment of hematological malignancies and solid tumors. The Company have developed an upgraded B cell maturation antigen (BCMA) targeted CAR-T product, CT053, which is its sole core product candidate. The Company conducts its...
Zonghai Li
Executive Chairman of the Board, Chief Executive Officer, Chief Scientific Officer
Huamao Wang
Chief Operating Officer, Executive Director
Wei Wang
Vice President
Address
Building 12
No.388 Yindu Road, Xuhui District
Shanghai, SHA
KY1-1205
China